FDA clearances allow QT Imaging’s breast scanner to be used in medical settings to capture images of the breast using ultrasound (both reflection and transmission / speed-of-sound modalities) for all women above 18 years old.

Additionally, the more recent clearance (K220933) allows quantitative measurement of the fibroglandular tissue (both volume & ratio to total breast volume), which can be useful for breast density assessments and monitoring therapies.

The device is not approved to replace mammography for screening. It is an adjunct / supplemental modality with advantages (no compression, no ionizing radiation) but not a substitute under current cleared uses.

QTI FDA Summary